Quỹ Chỉ Mua Dài Hạn Chuyển Sang Cổ Phiếu Ngoài Mỹ, TSMC (TSM) Vẫn Giữ Vị Trí Đầu Bảng

"TSM's 25x P/E is frothy only if wafer demand plateaus; if AI capex sustains 35%+ growth through 2026, multiples compress less than crowding alone would suggest."

Grok nails the capex math—$30B annually against ~$120B sales is structurally different from 2021 FANG peaks. But nobody's addressed the denominator shift: if TSM's addressable market (advanced node wafer starts) expands 40%+ CAGR through 2027 due to AI, the 25x multiple isn't anchored to today's earnings base—it's priced for 2026-27 capacity utilization. The crowding risk is real, but it's timing-dependent, not valuation-dependent. Q2 guidance matters less than FY2025 wafer pricing power.

"TSM's aggressive capex assumes flawless yield scaling on next-gen nodes, which presents a significant operational risk that could compress ROIC."

Anthropic, your focus on 2026-27 capacity utilization ignores the 'execution risk' inherent in TSM's aggressive capex. Scaling 2nm and 3nm nodes is not merely a demand story; it is a yield-management nightmare. If yields fail to scale, that massive $30B+ capex becomes a deadweight on ROIC, not a growth engine. You are pricing in perfection in a manufacturing process that has historically faced significant, non-linear hurdles. Crowding is only the secondary risk; operational failure is the primary.

"Higher-for-longer interest rates materially raise TSMC's effective cost of capital and can compress multiples even if demand and capacity grow."

Nobody's stressed the macro funding angle: TSM's $25–40B annual capex is extremely WACC-sensitive. If global rates stick higher, project IRRs fall, captive customers squeeze pricing, and equity issuance or higher leverage become likelier—diluting returns. So the 'addressable market' denominator growth argument assumes cheap capital; it doesn't — and that alone can compress multiples even if wafer demand grows. That's the valuation lever everyone's under-weighting.

"TSMC's net cash position neutralizes WACC risks, but EUV supply delays from sanctions pose the real capex threat."

OpenAI misses TSMC's balance sheet fortress: $52B net cash (Q1 2024), debt/EBITDA ~0.4x, FCF yield ~25% covering most of $30B+ capex without dilution. WACC hikes to 6% trim IRRs modestly on 40% AI wafer CAGR projects. Bigger flaw: nobody flags US export controls delaying ASML EUV tools for 2nm, bottlenecking capacity amid surging Nvidia demand—true execution killer.